Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAG | P20916 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.44 |
| ▸ | LGALS3 | P17931 | 5/20 | 0.44 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.44 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.44 |
| ▸ | LGALS7; LGALS7B | P47929 | 2/20 | 0.41 |
| ▸ | SELE | P16581 | 1/20 | 0.41 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.41 |
| ▸ | HRAS | P01112 | 1/20 | 0.40 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.40 |
| ▸ | FGF1 | P05230 | 1/20 | 0.40 |
| ▸ | FGF2 | P09038 | 1/20 | 0.40 |
| ▸ | VEGFA | P15692 | 1/20 | 0.40 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16153926 | 0.88 | SLC6A2 (0.47) | MAGSLC6A2HRASPOLB | |
| SCHEMBL9187189 | 0.86 | L3MBTL1 (0.50) | MAGL3MBTL1SLC6A2LGALS3LGALS7; LGALS7B | |
| SCHEMBL7717956 | 0.85 | MAG (0.58) | MAGL3MBTL1SLC6A2LGALS3LGALS8 | |
| SCHEMBL16153923 | 0.85 | MAG (0.58) | MAGL3MBTL1SLC6A2LGALS3LGALS8 | |
| SCHEMBL542353 | 0.85 | MAG (0.58) | MAGL3MBTL1SLC6A2LGALS3LGALS8 | |
| SCHEMBL7717946 | 0.85 | MAG (0.58) | MAGL3MBTL1SLC6A2LGALS3LGALS8 | |
| SCHEMBL542355 | 0.85 | MAG (0.58) | MAGL3MBTL1SLC6A2LGALS3LGALS8 | |
| SCHEMBL5308210 | 0.84 | L3MBTL1 (0.54) | MAGL3MBTL1HRASPOLB | |
| SCHEMBL1836110 | 0.84 | L3MBTL1 (0.54) | MAGL3MBTL1HRASPOLB | |
| SCHEMBL15028629 | 0.84 | MAPK1 (0.55) | LGALS3LGALS8LGALS4VEGFA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140303363-A1 | Preparation and Use of Isolactosamine and Intermediates therefor | GLYCOM A/S (DK) | 2014-10-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140303363-A1 | Preparation and Use of Isolactosamine and Intermediates therefor | GALE, B4GALT1, GNE | MAG 320/4885L3MBTL1 1527/4885SLC6A2 3154/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.